Filip Janku Insider Trades & Stock Holdings

Chief Medical Officer · Monte Rosa Therapeutics, Inc. · Latest filing Jun 29, 2026

Filip Janku, Chief Medical Officer at Monte Rosa Therapeutics, Inc. has 6 Form 4 trades on file since Jun 23, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($780.30K), net -$780.30K. Latest filing: disposed of 6K shares of $GLUE on Jun 29, 2026 at $22.95.

Trades on file

6

Open-market bought

$0

Open-market sold

$780.30K

Net open-market

-$780.30K

Latest filing

Jun 29, 2026

All insider trades by Filip Janku

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 29, 2026	$GLUE	Sell (Open-market sale) 10b5-1	6K	$22.95	$137.70K			-2.7%	-9.8%		Chief Medical Officer		Read
Jun 29, 2026	$GLUE	Buy (Option exercise)	6K	$7.56	$45.36K			-2.7%	-9.8%		Chief Medical Officer		Read
Jun 24, 2026	$GLUE	Sell (Open-market sale) 10b5-1	30K	$21.42	$642.60K			+15.2%	+9.3%		Chief Medical Officer		—
Jun 24, 2026	$GLUE	Buy (Option exercise)	30K	$7.56	$226.80K			+15.2%	+9.3%		Chief Medical Officer		—
Jun 23, 2026	$GLUE	Sell (Option exercise)	6K	$0	—			+16.9%	+11.2%		Chief Medical Officer		—
Jun 23, 2026	$GLUE	Buy (Option exercise)	6K	$7.56	$45.36K			+16.9%	+11.2%		Chief Medical Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Filip Janku traded

• $GLUE

Frequently asked questions

Has Filip Janku been buying or selling stock?

Filip Janku has 0 open-market purchases and 2 open-market sales on file, net -$780.30K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Filip Janku's latest insider trade?

disposed of 6K shares of $GLUE on Jun 29, 2026 at $22.95.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.